Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Conferences
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2019
September
19
ACLA blasts FDA's 'troubling actions' on pharmacogenetic tests
Biovica applies DiviTum in breast cancer study
Amgen enlists Adaptive's clonoSeq in broad blood cancer deal
Why blood cultures must come first in suspected sepsis
Page 1 of 1